New Delhi, April 16 (IANS) Monitoring blood levels of DNA fragments shed by dying tumour cells may accurately predict cancer recurrence, according to a new study.
Researchers at New York University-Langone Health, US, focussed on nearly 600 men and women from Europe, North America, and Australia, with stage III melanoma — among the most aggressive forms of skin cancer.
The study showed that approximately 80 per cent of skin cancer patients with detectable levels of circulating tumour DNA (ctDNA), before they started treatment to suppress their tumours, went on to experience recurrence.
The disease was also found to return more than four times faster in this group than in those with no detectable levels of the biomarker, and the higher their levels, the faster the cancer returned.
“Our findings suggest that circulating tumour DNA tests could help oncologists identify which melanoma patients are most likely to respond well to therapy,” said study lead author Mahrukh Syeda, a research scientist at NYU Grossman School of Medicine.
“In the future, such assessments may be used routinely in the clinic to help guide treatment decisions,” added Syeda.
In the study, published in the journal The Lancet Oncology, the team also found that nearly all of those with detectable levels of ctDNA at three, six, nine, or 12 months into treatment experienced melanoma recurrence.
As a result, the researchers said, if the gene fragments are not observable prior to therapy but appear later on, this could indicate that the disease might be worsening.
Syeda said that the ctDNA method works by focusing on the most common mutations in the genetic code in melanoma cells.
The mutated DNA spills into surrounding blood as the cells break down.
Further, the team showed that assessing ctDNA levels were as good or better at predicting recurrence than other experimental tests that examine a tumour itself, such as those that measure immune activity within a group of cancer cells.
–IANS
rvt/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
